Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Aptamer Group and BaseCure Therapeutics join hands for new targeted gene therapies
Optimer delivery vehicles could increase uptake of the siRNA therapy into the target cells
We are talking to vendors to develop ERP for IPC so that our whole working process turns digital
Dr Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission (IPC), speaks exclusively to…
AI, Big Data will be the most impactful emerging technologies for pharma in 2023: GlobalData
The two technologies together are expected to play an important role in the industry in optimising a wide range of processes, from…
BDR Pharma launches generic antibiotic range medicine, Ceftazidime Avibactum
XAVITAZ is useful in treating resistant gram-negative infections, including many Ceftazidime-resistant strains
Researchers at Ben-Gurion University identifies protein that could prevent ageing
Research finds that a protein called SIRT6 is a key regulator of mitochondrial function in the brain and its absence seems to…
Enzene Biosciences raises $50 million to boost manufacturing capabilities and grow in global markets
The funding round is led by Alkem Laboratories and new investors, Eight Roads Ventures and F-Prime Capital
Indian neuroscientist develops first therapy for refractory epilepsy
Reddy, an Indian citizen, is considered to be among the top two per cent of scientists worldwide and has published 225 papers,…
Alkem becomes first Indian company to launch novel antibiotic for MDR infections
This is in line with company’s endeavour to ensure affordability, accessibility and availability while saving the lives of…
Sun Pharma acquires Disperzyme and Phlogam brands to strengthen its anti-inflammatory portfolio
Disperzyme and Phlogam are fixed-dose combinations of proteolytic enzymes and bioflavonoid viz Tryspin, Bromelain and Rutoside…